Colorectal Cancer Clinical Trial
Official title:
MiVideo - Video Visit Summary for Cancer Patients
| Verified date | March 2017 |
| Source | University of Michigan |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Cancer patients about to begin chemotherapy receive large amounts of information regarding
their prognosis, how chemotherapy improves their prognosis, and the usual side effects of
the chemotherapy during their first visit to the oncologist. Prior studies have documented
that less than half of this information is retained after the visit, making it difficult for
patients to participate in their care and difficult for them to enlist the help of their
social support. The MiVideo project allows the physician to create a custom 5-minute summary
video summary of a pre-chemotherapy clinic visit and upload it to a secure web site. The
video will emphasize the major points of the forty-five minute office discussion, allowing
patients to review the physicians' recommendations and share the information and
recommendations with others. By providing the patient with this re-cap of their visit, the
investigators hope to engage them more actively in their cancer treatment. Making the
information available to friends and family can also help a patient receive both
intellectual and emotional support during the course of treatment. The primary endpoint of
this study is improvement of patient care, not research activity.
Primary Hypothesis: Creating a 5-minute video summarizing information about diagnosis,
stage, chemotherapy treatment plan, and anticipated side effects for patients starting
chemotherapy for colon cancer will not significantly lengthen the pre-chemotherapy clinic
visit as compared to visits that do not include video production.
| Status | Completed |
| Enrollment | 58 |
| Est. completion date | March 2015 |
| Est. primary completion date | March 2015 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Age 18-80 - Diagnosis of colon cancer with treatment plan to include chemotherapy - Sufficient command of English language to read and understand consent and survey forms - Working email address and access to the Internet (computer, tablet, smartphone) to view treatment summary video Exclusion Criteria: - Previous history of chemotherapy or cancer (excepting in situ cancers) - History of drug or alcohol abuse or unmedicated mental or psychiatric disorder - Medical history or diagnosis of debilitating medical disorder such as progressive muscle paralysis, advanced cardiac, respiratory, or renal disease, or AIDS |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan |
| Lead Sponsor | Collaborator |
|---|---|
| University of Michigan |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Length of visit (minutes) | Day of consent | ||
| Secondary | Number of patient views of their visit summary prior to chemotherapy | 2-4 weeks post-visit | ||
| Secondary | Number of video summary shares prior to chemotherapy | 2-4 weeks post visit | ||
| Secondary | Participant-rated usefulness of video summary | Usefulness is measured using a short post-video online survey. | 2-4 weeks post visit |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |